#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal cancer metastatic Multiple system atrophy Follicular lymphoma Interstitial lung disease Vascular malformation Extra-osseous Ewing's sarcoma Mantle cell lymphoma Hereditary motor and sensory neuropathy Hodgkin's disease refractory Chronic graft versus host disease Cutaneous calcification Malignant fibrous histiocytoma Oesophageal squamous cell carcinoma stage II Intracranial calcification Haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Life with Disease Hairy cell leukaemia recurrent – Basic Information Chronic granulomatous disease – Trials in Disease Ocular melanoma – Diagnostics Congenital hypotransferrinaemia – Trials in Disease Leiomyosarcoma recurrent – Treatment Richter’s syndrome Skin angiosarcoma – Treatment Hereditary neuropathic amyloidosis – Basic Information Hairy cell leukaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amiloride Hydrochloride Aripiprazole Etifoxine Hydrochloride Flutemetamol (18F) Camizestrant Temocillin Sodium Vitamin A Bp Terbinafine Hydrochloride Delandistrogene Moxeparvovec Gilteritinib Vepdegestrant Idelalisib Aluminium Hydroxide Dipyridamole Air, Medicinal Ocrelizumab Mk-1167 Bi 1015550 Linezolid Mdna11 More therapies…

    Learn about Your Condition

    Infection Status epilepticus Haemorrhagic stroke Nodular melanoma Hepatic fibrosis Acute coronary syndrome Tourette's disorder Polymyositis Dystonia Vulvovaginal pain Tachypnoea Endocarditis Optic ischaemic neuropathy Muscle hypertrophy Primary hyperthyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2yx Bqmwjaimz Di Scyrcz Mazxlidwqvn Bl 1vgt Mhuruybmei 1jfezy Fftnag

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor negative HER2 positive breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Antiemetics And Antinauseants
    • Antipsychotics
    • Corticosteroids, Plain
    Austria Belgium Czechia France Germany Greece +5

  • Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Belzutifan
    • Lenvatinib
    Croatia Czechia Denmark Finland France Germany +8

  • Study on the Safety of GRWD5769 Alone and with Cemiplimab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Cemiplimab
    • Grwd5769
    France Spain

  • Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Belgium Denmark France Germany Italy Poland +1

  • Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma stage IV
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Sunitinib
    Austria Belgium Czechia Denmark Finland France +7

  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France Italy

  • Study of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Mcla-129
    • Carboplatin
    • Docetaxel
    Belgium France Germany Italy The Netherlands Spain

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany

  • Study of Mirvetuximab Soravtansine compared to standard chemotherapy in women with platinum-resistant advanced ovarian cancer with high folate receptor expression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal sarcoma
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Prednisolone Acetate
    • Doxorubicin Hydrochloride
    • Mirvetuximab Soravtansine
    France

  • Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Tivozanib
    • Nivolumab
    Belgium Czechia France Germany Italy Poland +2
Previous Page
1 … 38 39 40 41 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!